Rivero Berti, I.; Gambaro, R.C.; Limeres, M.J.; Huck-Iriart, C.; Svensson, M.; Fraude-El Ghazi, S.; Pretsch, L.; Si, S.; Lieberwirth, I.; Landfester, K.;
et al. Encapsulation of Dexamethasone into mRNA–Lipid Nanoparticles Is a Promising Approach for the Development of Liver-Targeted Anti-Inflammatory Therapies. Int. J. Mol. Sci. 2024, 25, 11254.
https://doi.org/10.3390/ijms252011254
AMA Style
Rivero Berti I, Gambaro RC, Limeres MJ, Huck-Iriart C, Svensson M, Fraude-El Ghazi S, Pretsch L, Si S, Lieberwirth I, Landfester K,
et al. Encapsulation of Dexamethasone into mRNA–Lipid Nanoparticles Is a Promising Approach for the Development of Liver-Targeted Anti-Inflammatory Therapies. International Journal of Molecular Sciences. 2024; 25(20):11254.
https://doi.org/10.3390/ijms252011254
Chicago/Turabian Style
Rivero Berti, Ignacio, RocÃo Celeste Gambaro, MarÃa José Limeres, Cristián Huck-Iriart, Malin Svensson, Silvia Fraude-El Ghazi, Leah Pretsch, Shutian Si, Ingo Lieberwirth, Katharina Landfester,
and et al. 2024. "Encapsulation of Dexamethasone into mRNA–Lipid Nanoparticles Is a Promising Approach for the Development of Liver-Targeted Anti-Inflammatory Therapies" International Journal of Molecular Sciences 25, no. 20: 11254.
https://doi.org/10.3390/ijms252011254
APA Style
Rivero Berti, I., Gambaro, R. C., Limeres, M. J., Huck-Iriart, C., Svensson, M., Fraude-El Ghazi, S., Pretsch, L., Si, S., Lieberwirth, I., Landfester, K., Cacicedo, M. L., Islan, G. A., & Gehring, S.
(2024). Encapsulation of Dexamethasone into mRNA–Lipid Nanoparticles Is a Promising Approach for the Development of Liver-Targeted Anti-Inflammatory Therapies. International Journal of Molecular Sciences, 25(20), 11254.
https://doi.org/10.3390/ijms252011254
